Partners
Investments
Marketing & Client Service
Product Management
Finance, Operations and Technology
Trading
“Pharma and Biotech R&D productivity is finally on the rise, yielding exciting new product cycles to drive industry growth. Couple that with a resurgence in M&A activity to leverage existing infrastructure, and we are seeing tremendous opportunities to generate investment returns within the therapeutics space.”
Matthew R. Renna
Managing Partner
Matt is a Managing Partner at Westfield and a member of the firm’s Investment Committee, responsible for research coverage of Biopharma & Life Sciences.
He joined Westfield Capital Management in 2013 after serving as a Health Care Portfolio Manager at Vinik Asset Management. His prior experience includes roles as Director on the SMID Growth Equity team at BlackRock, Senior Equity Analyst at RA Capital Management, and Director of Healthcare/Biotechnology at Soleil Securities Corporation, Neponset Equity Research. Matt began his career in the Health Care industry at Merck & Co., and transitioned to equity research as a Senior Research Associate at Leerink Swann, covering Specialty Pharmaceuticals.
Matt earned his M.B.A. from the Carroll School of Management at Boston College in 2006, an M.S. from Boston University in 2001, and a B.S. from Boston University in 1999, graduating magna cum laude.
Managing Partner
Health Care Sector Head
Covering Biopharma & Life Sciences
2013 - Present: Westfield Capital Management
2012 - 2013: Vinik Asset Management
2009 - 2012: BlackRock, Inc.
2008 - 2009: RA Capital Management
2005 - 2008: Soleil Securities Corporation
2004 - 2005: Leerink Swann LLC
2001 - 2004: Merck & Co., Inc.
2006: Boston College, Carroll School of Management, MBA
2001: Boston University, MS
1999: Boston University, BS
|
|
